On April 27, 2026, Veradermics, Inc. disclosed that its experimental oral hair-loss drug VDPHL01 hit the primary efficacy ...

A NEW two-in-one jab could be more effective than Wegovy and weight loss pills, as it targets “harmful” fat hidden deep ...

Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering ...

The extended-release minoxidil tablet could be the first FDA-approved oral treatment for pattern hair loss in about 30 years ...

A recent FDA approval means consumers now have two GLP-1 weight loss pills to choose from as an alternative to the traditional injections.

A proprietary extended-release oral minoxidil tablet yielded rapid and robust hair growth in men with pattern hair loss, ...

This treatment is now in late-stage testing ahead of potential FDA review.

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?

Veradermics’ experimental oral minoxidil pill, VDPHL01, has delivered strong results in late-stage trials for male pattern ...

At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be ...

The FDA has approved Foundayo, a new weight-loss pill that could give Eli Lilly an edge over other drugmakers. Here's how it ...

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...